Wednesday
May 14, 2025
7:00 AM ET
Benitec Biopharma Releases Third Quarter 2025 Financial Results
Wednesday
March 19, 2025
7:00 AM ET
Benitec Biopharma Reports Positive Interim Clinical Results for Three Subjects Treated with BB-301 in Phase 1b/2a Study to be Presented at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference
Friday
February 14, 2025
8:10 AM ET
Benitec Biopharma Releases Second Quarter 2025 Financial Results and Provides Operational Update
Friday
February 14, 2025
8:00 AM ET
Benitec Biopharma Announces Acceptance of Late- Breaking Oral Abstract for the BB-301 Phase 1b/2a Clinical Study at the Muscular Dystrophy Association Clinical and Scientific Conference